Email this article CEREBROVASCULAR DISEASES: THE POSSIBILITIES AND EFFICIENCY OF METABOLIC THERAPY
- Authors: Umarova K.Y.1, Kazakov A.Y.2, Chugunov A.V.2, Makeeva M.M.3
-
Affiliations:
- Chechen State University
- N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- City Polyclinic Three
- Issue: Vol 7, No 2 (2013)
- Pages: 88-93
- Section: PHARMACOTHERAPY
- Published: 15.07.2014
- URL: https://klinitsist.abvpress.ru/Klin/article/view/34
- DOI: https://doi.org/10.17650/1818-8338-2013-2-88-93
- ID: 34
Cite item
Full Text
Abstract
Acute and chronic brain ischemia is accompanied by complex metabolic rearrangements in the neurons. The ability of the cells to survive is largely determined by the presence of energy substrates and oxygen, the synthesis of neurotransmitters, and some other factors. The increased
persistence of nerve tissue in ischemia and chances of recovering the impaired function can be achieved by the use of neuroprotective and neurotrophic agents. The efficiency of neurometabolic therapy is considered using Ceraxon and Actovegin as an example. It is emphasized that the
efficiency of their administration can be achieved by the mandatory concurrent use of a wide range of nondrug treatments.
About the authors
Kh. Ya. Umarova
Chechen State University
Author for correspondence.
Email: khadi700@mail.ru
Medical Faculty Russian Federation
A. Yu. Kazakov
N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaRussian Federation
A. V. Chugunov
N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaRussian Federation
M. M. Makeeva
City Polyclinic ThreeRussian Federation
References
Supplementary files
